Search

everythinglearnresearchcommunity

for

Search:↓

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

A new model helps predict treatment success in girls with early puberty.

Non-daily Dutasteride is more cost-effective and has lower cancer incidence than daily treatment.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

Pexidartinib often causes liver issues and fatigue, especially in women.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Created method to measure doxazosin mesylate and finasteride together.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

The assay effectively detects hormonal activity of certain chemicals.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

A trial found that using finasteride, a hair growth drug, can be effectively measured by comparing before and after photos.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

Measuring OPC-17116 in hair can reliably indicate drug exposure and timing.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.